Varaico: Literature-Extracted Genetic Variants

Gene:FGFR3
Variant:p.K650N
Back to variants list

FGFR3

NM_000142.5:p.K650N

Associated Papers

Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia.

Irving M et al.

Advances in Therapy, 2026

Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.

Tangermann C et al.

Nature Genetics, 2026

41361008 (PubMed )
Supplement: 41588_2025_2431_MOESM3_ESM.xlsx › S12_Cell_lines

KBG Syndrome: A Case Report and Longitudinal Assessment of Long-Acting Recombinant Human Growth Hormone Therapy.

Nan H et al.

Clinical Case Reports, 2026

41487979 (PubMed )
Supplement: CCR3-14-e71744-s001.pdf

Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients.

Smolenschi C et al.

Npj Precision Oncology, 2025

Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia.

Demuynck B et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2025

Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.

Hoskins EL et al.

Npj Precision Oncology, 2025

40610725 (PubMed )
Supplement: 41698_2025_889_MOESM5_ESM.xlsx › Sheet1

Mining cancer genomes for change-of-metabolic-function mutations.

Tu KJ et al.

Communications Biology, 2023

37950065 (PubMed )
Supplement: 42003_2023_5475_MOESM2_ESM.pdf

Cilia kinases in skeletal development and homeostasis.

Abraham SP et al.

Developmental Dynamics : an Official Publication of the American Association of Anatomists, 2022

Are transient protein-protein interactions more dispensable?

Ghadie MA et al.

Plos Computational Biology, 2022

35404956 (PubMed )
Supplement: pcbi.1010013.s002.xlsx › _D__Lit-SI_disMut_edgotypes

Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer.

Nakamura IT et al.

Npj Precision Oncology, 2021

Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment.

Li J et al.

Aging, 2021

34160364 (PubMed )
Supplement: aging-13-203175-s003.xlsx › ___1

Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.

Stranneheim H et al.

Genome Medicine, 2021

33726816 (PubMed )
Supplement: 13073_2021_855_MOESM3_ESM.xlsx › Reported_genes_and_variants

Mutation Edgotype Drives Fitness Effect in Human.

Ghadie M et al.

Frontiers in Bioinformatics, 2021

36303776 (PubMed )
Supplement: Table2.XLSX › _D__Lit-SI_pathMt_edgotype

Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene.

Kariya H et al.

The Journal of Dermatology, 2020

Identification of pathogenic missense mutations using protein stability predictors.

Gerasimavicius L et al.

Scientific Reports, 2020

32958805 (PubMed )
Supplement: 41598_2020_72404_MOESM2_ESM.xlsx › ClinVar

Mild osteochondrodysplasia with acanthosis nigricans in a short-statured Taiwanese family due to the p.Lys650Gln mutation in FGFR3.

Lin WD et al.

Pediatrics and Neonatology, 2019

Estimating dispensable content in the human interactome.

Ghadie M et al.

Nature Communications, 2019

31324802 (PubMed )
Supplement: 41467_2019_11180_MOESM6_ESM.xlsx › _D__IntAct-SI_disease_mut

Acanthosis nigricans, hypochondroplasia, and FGFR3 mutations: Findings with five new patients, and a review of the literature.

Muguet Guenot L et al.

Pediatric Dermatology, 2019

Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.

Terasawa S et al.

Congenital Anomalies, 2019

Identification of a novel mutation of FGFR3 gene in a large Chinese pedigree with hypochondroplasia by next-generation sequencing: A case report and brief literature review.

Yao G et al.

Medicine, 2019

Computational analysis reveals histotype-dependent molecular profile and actionable mutation effects across cancers.

Heim D et al.

Genome Medicine, 2018

30442178 (PubMed )
Supplement: 13073_2018_591_MOESM4_ESM.xlsx › Table_S2

Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.

Yasuda M et al.

The Journal of Dermatology, 2018

Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration.

Ren Y et al.

Prenatal Diagnosis, 2018

Integrative omics analyses broaden treatment targets in human cancer.

Sengupta S et al.

Genome Medicine, 2018

30053901 (PubMed )
Supplement: 13073_2018_564_MOESM2_ESM.xlsx › 13

Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.

Bunney TD et al.

Structure (london, England : 1993), 2018

29478821 (PubMed )
Supplement: mmc3.pdf

Familial acanthosis nigricans with p.K650T FGFR3 mutation.

Fukuchi K et al.

The Journal of Dermatology, 2018

A novel S269C mutation in fibroblast growth factor receptor 3 in a Japanese child with hypochondroplasia.

Takahashi I et al.

Human Genome Variation, 2018

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.

Guyard A et al.

Respiratory Research, 2017

Achondroplasia: Development, pathogenesis, and therapy.

Ornitz DM et al.

Developmental Dynamics : an Official Publication of the American Association of Anatomists, 2017

Acanthosis nigricans in a Japanese boy with hypochondroplasia due to a K650T mutation in FGFR3.

Hirai H et al.

Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology, 2017

Familial hypochondroplasia and acanthosis nigricans with FGFR3 K650T mutation.

Cossiez Cacard MA et al.

Journal of the European Academy of Dermatology and Venereology : Jeadv, 2016

Altered FGF signalling in congenital craniofacial and skeletal disorders.

Moosa S et al.

Seminars in Cell & Developmental Biology, 2016

Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.

Patani H et al.

Oncotarget, 2016

Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation.

Ichiyama S et al.

Journal of the European Academy of Dermatology and Venereology : Jeadv, 2016

Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.

McDonell LM et al.

Human Molecular Genetics, 2015

Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.

Helsten T et al.

Cancer Metastasis Reviews, 2015

Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations.

Gallo LH et al.

Cytokine & Growth Factor Reviews, 2015

Fibroblast growth factor signaling in skeletal development and disease.

Ornitz DM et al.

Genes & Development, 2015

Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach.

Chitty LS et al.

Prenatal Diagnosis, 2015

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2015

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial.

Quintela-Fandino M et al.

Molecular Oncology, 2014

Suppression of severe achondroplasia with developmental delay and acanthosis nigricans by the p.Thr651Pro mutation.

Manickam K et al.

American Journal of Medical Genetics. Part A, 2014

Hypochondroplasia, Acanthosis Nigricans, and Insulin Resistance in a Child with FGFR3 Mutation: Is It Just an Association?

Mustafa M et al.

Case Reports in Endocrinology, 2014

Detection of a de novo Y278C mutation in FGFR3 in a pregnancy with severe fetal hypochondroplasia: prenatal diagnosis and literature review.

Chen CP et al.

Taiwanese Journal of Obstetrics & Gynecology, 2013

1–50 of 84 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."